Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans

Verfasser / Beitragende:
[R. Weber, A. Pechere-Bertschi, D. Hayoz, V. Gerc, R. Brouard, J. P. Lahmy, H. R. Brunner, M. Burnier]
Ort, Verlag, Jahr:
1997
Enthalten in:
Hypertension, 30/5(1997-11), 1121-7
Format:
Artikel (online)
ID: 439514967